Study to Evaluate the Safety of CB-280 in Patients With Cystic Fibrosis

NCT04279769 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

32

Enrollment

INDUSTRY

Sponsor class

Conditions

Cystic Fibrosis

Interventions

DRUG: CB-280
DRUG: Placebos

Sponsor

Calithera Biosciences, Inc